Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPSAP36 (ribosomal protein SA pseudogene 36) is classified as a non-functional gene copy related to the ribosomal protein SA (RPSA) gene family. Pseudogenes are genetic sequences similar to functional genes but lack the ability to encode active proteins due to mutations such as frameshifts, premature stop codons, or missing regulatory elements. While some RPSA pseudogenes in other species have been studied for potential regulatory roles, there is no evidence that RPSAP36 in humans is functional or involved in any therapeutic pathway[5]. The canonical functional gene (RPSA) encodes a ribosomal protein, also acting as a cell surface receptor (laminin receptor), with roles in cancer and infectious disease[7]. However, pseudogenes like RPSAP36 are typically considered non-coding "genomic fossils" without therapeutic relevance.
None. No mechanism of action is applicable as no drugs or therapies target this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 36 (RPSAP36).